These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29766859)

  • 1. Surgical Management of Implantation-Related Complications of the Subcutaneous Implantable Cardioverter-Defibrillator.
    Brouwer TF; Driessen AHG; Olde Nordkamp LRA; Kooiman KM; de Groot JR; Wilde AAM; Knops RE
    JACC Clin Electrophysiol; 2016 Feb; 2(1):89-96. PubMed ID: 29766859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use and outcomes of subcutaneous implantable cardioverter-defibrillator (ICD) after transvenous ICD extraction: An analysis of current clinical practice and a comparison with transvenous ICD reimplantation.
    Viani S; Migliore F; Tola G; Pisanò ECL; Russo AD; Luzzi G; Sartori P; Piro A; Rordorf R; Forleo GB; Rago A; Segreti L; Bertaglia E; Biffi M; Lovecchio M; Valsecchi S; Diemberger I; Bongiorni MG
    Heart Rhythm; 2019 Apr; 16(4):564-571. PubMed ID: 30366163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-year follow-up of the initial Dutch subcutaneous implantable cardioverter-defibrillator cohort: Long-term complications, replacements, and battery longevity.
    Quast ABE; van Dijk VF; Yap SC; Maass AH; Boersma LVA; Theuns DA; Knops RE
    J Cardiovasc Electrophysiol; 2018 Jul; 29(7):1010-1016. PubMed ID: 29626366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anesthesia care for subcutaneous implantable cardioverter/defibrillator placement: a single-center experience.
    Essandoh MK; Portillo JG; Weiss R; Otey AJ; Zuleta-Alarcon AN; Humeidan ML; Torres JL; Flores AS; Castellon-Larios K; Abdel-Rasoul M; Andritsos MJ; Perez WJ; Stein EJ; Turner KR; Dimitrova GT; Awad H; Bhandary SP; Tripathi RS; Joseph NC; Hummel JD; Augostini RS; Kalbfleisch SJ; Tyler JD; Houmsse M; Daoud EG
    J Clin Anesth; 2016 Jun; 31():53-9. PubMed ID: 27185678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transvenous subcutaneous implantation technique of the cardioverter/defibrillator].
    Block M; Hammel D; Borggrefe M; Scheld HH; Breithardt G
    Herz; 1994 Oct; 19(5):259-77. PubMed ID: 8001899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: A cost-effectiveness evaluation.
    Healy CA; Carrillo RG
    Heart Rhythm; 2015 Jul; 12(7):1565-73. PubMed ID: 25839113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A propensity matched case-control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator.
    Honarbakhsh S; Providencia R; Srinivasan N; Ahsan S; Lowe M; Rowland E; Hunter RJ; Finlay M; Segal O; Earley MJ; Chow A; Schilling RJ; Lambiase PD
    Int J Cardiol; 2017 Feb; 228():280-285. PubMed ID: 27865198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience of subcutaneous and transvenous implantable cardioverter defibrillators in children and teenagers.
    Pettit SJ; McLean A; Colquhoun I; Connelly D; McLeod K
    Pacing Clin Electrophysiol; 2013 Dec; 36(12):1532-8. PubMed ID: 24033753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU; Goldenberg I; Moss AJ
    Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined subcutaneous implantable cardioverter defibrillator and pacemaker devices in complex congenital heart disease: a single-center experienced based study.
    Sarubbi B; Ciriello GD; Papaccioli G; Correra A; Romeo E; Grimaldi N; Colonna D; Palma M
    J Interv Card Electrophysiol; 2023 Oct; ():. PubMed ID: 37878161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection and mortality after implantation of a subcutaneous ICD after transvenous ICD extraction.
    Boersma L; Burke MC; Neuzil P; Lambiase P; Friehling T; Theuns DA; Garcia F; Carter N; Stivland T; Weiss R;
    Heart Rhythm; 2016 Jan; 13(1):157-64. PubMed ID: 26341604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous implantable cardioverter defibrillator after transvenous lead extraction: safety, efficacy and outcome.
    Giacomin E; Falzone PV; Dall'Aglio PB; Pittorru R; De Lazzari M; Vianello R; Bertaglia E; Tarzia V; Iliceto S; Gerosa G; Migliore F
    J Interv Card Electrophysiol; 2022 Jul; ():. PubMed ID: 35831772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The subcutaneous cardioverter-defibrillator: When less is more].
    Kuschyk J; Rudic B; Akin I; Borggrefe M; Röger S
    Herzschrittmacherther Elektrophysiol; 2015 Jun; 26(2):123-8. PubMed ID: 26058997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The wearable cardioverter-defibrillator in a real-world clinical setting: experience in 102 consecutive patients.
    Erath JW; Vamos M; Sirat AS; Hohnloser SH
    Clin Res Cardiol; 2017 Apr; 106(4):300-306. PubMed ID: 27888304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of complications and shocks in paediatric and young transvenous and subcutaneous implantable cardioverter-defibrillator patients.
    Quast ABE; Brouwer TF; Kooiman KM; van Dessel PFHM; Blom NA; Wilde AAM; Knops RE
    Neth Heart J; 2018 Dec; 26(12):612-619. PubMed ID: 30377940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial experience with the subcutaneous implantable cardioverter-defibrillator in a single Japanese center.
    Nishii N; Tachibana M; Morimoto Y; Kawada S; Miyoshi A; Sugiyama H; Nakagawa K; Watanabe A; Nakamura K; Morita H; Ito H
    J Arrhythm; 2017 Aug; 33(4):338-341. PubMed ID: 28765769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator.
    Knops RE; Olde Nordkamp LR; de Groot JR; Wilde AA
    Heart Rhythm; 2013 Aug; 10(8):1240-3. PubMed ID: 23707489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of The Wearable Cardioverter Defibrillator (WCD) as a Bridging-Therapy before Implantation of a Cardioverter Defibrillator (ICD).
    Doz P; Sperzel J
    J Atr Fibrillation; 2016; 8(5):1247. PubMed ID: 27909469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator.
    Tanawuttiwat T; Garisto JD; Salow A; Glad JM; Szymkiewicz S; Saltzman HE; Kutalek SP; Carrillo RG
    Pacing Clin Electrophysiol; 2014 May; 37(5):562-8. PubMed ID: 24762055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of the subcutaneous implantable cardioverter-defibrillator for reducing sudden cardiac death.
    Sanghera R; Sanders R; Husby M; Bentsen JG
    Ann N Y Acad Sci; 2014 Nov; 1329():1-17. PubMed ID: 25308791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.